Target intelligence / Profile preview

Shortage in chiasmata 1 protein (SHOC1)

Target
SHOC1
Molecular classification
Other (Meiotic crossover formation protein)
01

Overview

The Shortage in chiasmata 1 protein (SHOC1) is involved in the formation of crossovers (chiasmata) between homologous chromosomes during meiosis, especially in plants like Arabidopsis and potato. Loss-of-function mutations in SHOC1 impair crossover formation, leading to meiotic errors and reduced fertility. The SHOC1 orthologue's role appears to be conserved in meiotic recombination processes across some eukaryotes but is mainly studied in plant systems. SHOC1 is not considered a conventional pharmacological or therapeutic target and is instead a genetic factor relevant to studies of meiosis and plant breeding. In potato, a “crossover shortage” phenotype has been linked to mutations in genes such as StMSH4, not in SHOC1 itself. In animals and humans, SHOC1 is not a commonly referenced gene/protein, and there is no evidence for it being a therapeutic target or biomarker. If you are seeking information about "chiasma shortage" or "shortage of chiasmata" as a cytological phenomenon in meiosis, this refers to the reduced physical linkages (chiasmata) between homologous chromosomes, not a specific molecular target. In such contexts, proteins like SHOC1 or MSH4 may be involved in the underlying biology, especially in plants.

Other names
SHOC1shortage in chiasmata 1 orthologue
02

Mechanism of action

Not applicable as no drugs target this protein

03

Biological functions

Crossover formation during meiosisGenetic recombination
04

Disease associations

Other (in crop breeding, may impact fertility and genetic diversity)
05

Safety considerations

Not applicable for therapeutic use

Beyond the preview

Go deeper on Shortage in chiasmata 1 protein (SHOC1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shortage in chiasmata 1 protein (SHOC1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call